test
Home / NDTV Profit / News / Laurus Labs Downplays Impact Of New US Pharma Tariffs On Branded Drugs

Laurus Labs Downplays Impact Of New US Pharma Tariffs On Branded Drugs

- ,
Lauras Labs derives 40% of its revenue from antiretroviral (ARV) drugs, which remain insulated from US tariffs.

from NDTV Profit https://ift.tt/gowlJH9
Laurus Labs Downplays Impact Of New US Pharma Tariffs On Branded Drugs Laurus Labs Downplays Impact Of New US Pharma Tariffs On Branded Drugs Reviewed by aamira sultan on September 26, 2025 Rating: 5

No comments:

Subscribe to: Post Comments ( Atom )
Powered by Blogger.